Rocket Pharmaceuticals Inc. (RCKT)
NASDAQ · Healthcare
Rocket Pharmaceuticals Inc. EPS 2016–2025
Rocket Pharmaceuticals Inc. annual/quarterly eps history and growth rate from 2019 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Rocket Pharmaceuticals Inc. eps for the quarter ending March 31, 2026 was $0.42, a 25.00% decrease year-over-year.
- Rocket Pharmaceuticals Inc. annual eps for 2025 was $2.01, a 26.37% decrease from 2024.
- Rocket Pharmaceuticals Inc. annual eps for 2024 was $2.73, a 6.51% decrease from 2023.
- Rocket Pharmaceuticals Inc. annual eps for 2023 was $2.92, a 10.43% decrease from 2022.
- Rocket Pharmaceuticals Inc. annual eps for 2022 was $3.26.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Rocket Pharmaceuticals Inc. EPS — FAQ
Rocket Pharmaceuticals Inc. (RCKT) eps over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Rocket Pharmaceuticals Inc.'s eps?
Rocket Pharmaceuticals Inc. (RCKT) reported eps of $-2.01 for fiscal 2025.
Where can I see RCKT's eps history?
The chart and table above show Rocket Pharmaceuticals Inc.'s eps by year and by quarter, including the growth rate.